Pfizer

Pfizer’s Covid Vaccine Protection Against Omicron Fades Just Weeks After Second And Third Doses, Study Finds
Forbes
Fri, 05/13/22 - 11:56 am
Pfizer
vaccines
COVID-19
Omicron variant
Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs
Yahoo/Bloomberg
Fri, 05/13/22 - 10:38 am
Pfizer
Biohaven
M&A
Pfizer: Pharma needs a business strategy for a digital world
Pharmaforum
Fri, 05/13/22 - 10:35 am
Pfizer
digital health
digital pharma
pandemic
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Pfizer 'intensively researching' long-lasting COVID-19 vaccine
Beckers Hospital Review
Thu, 05/12/22 - 10:48 pm
Pfizer
Albert Bourla
vaccines
COVID-19
Pfizer partner Biovac warns of production slump amid low COVID vaccine demand: report
Fierce Pharma
Thu, 05/12/22 - 10:46 pm
Pfizer
Biovac
BioNTech
vaccines
COVID-19
Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say
Endpoints
Thu, 05/12/22 - 10:19 am
Pfizer
Paxlovid
COVID-19
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
biotech
life sciences
hirings
Regeneron
Pfizer
Amgen
AbbVie
Moderna Therapeutics
CSL Behring
Waters Corporation
Daiichi Sankyo
Gilead Sciences
Grail
Emergent BioSolutions
resilience
Pfizer to acquire Biohaven in $11.6B bet on biotech’s migraine drugs
BioPharma Dive
Tue, 05/10/22 - 10:57 am
Pfizer
M&A
Biohaven
migraines
ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost effective, but their benefits are far from equal
Fierce Pharma
Tue, 05/10/22 - 10:50 am
ICER
Pfizer
Paxlovid
Merck
Ridgeback Biotherapeutics
molnupiravir
COVID-19
BioNTech's Q1 vaccine sales triple but it still flags full-year decline
Yahoo/Reuters
Mon, 05/9/22 - 10:35 am
BioNTech
earnings
vaccines
Pfizer
COVID-19
COVID vaccine makers shift focus to boosters
Yahoo/Reuters
Mon, 05/9/22 - 10:13 am
COVID-19
vaccines
boosters
Pfizer
Moderna Therapeutics
In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports
Endpoints
Thu, 05/5/22 - 11:34 pm
Biogen
earnings
SEC
Eli Lilly
Merck
Bristol Myers Squibb
Pfizer
AbbVie
Pfizer Is Poised to Shatter These 2 Records in 2022
Motley Fool
Thu, 05/5/22 - 10:41 am
Pfizer
earnings
Paxlovid
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return
Fierce Pharma
Wed, 05/4/22 - 05:46 pm
Pfizer
Albert Bourla
Pharma CEOs
FDA
Paxlovid
COVID-19
Another Pfizer gene therapy is free of FDA hold, but delay continues
Fierce Biotech
Tue, 05/3/22 - 10:53 pm
Pfizer
FDA
clinical trials
hemophilia A
gene therapy
giroctocogene fitelparvovec
Sangamo Therapeutics
Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt
Endpoints
Tue, 05/3/22 - 10:46 pm
Connect Biopharma
Pfizer
Bristol Myers Squibb
FDA
clinical trials
ulcerative colitis
CBP-307
Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales
CNBC
Tue, 05/3/22 - 10:34 pm
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Paxlovid's post-exposure protection flop hardly spells the end for Pfizer's COVID franchise: analysts
Fierce Pharma
Mon, 05/2/22 - 11:54 am
Pfizer
Paxlovid
COVID-19
antivirals
clinical trials
Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor
Fierce Pharma
Sat, 04/30/22 - 02:38 pm
Pfizer
vaccines
Kathrin Jansen
COVID-19

Pages